Sponsor:
Carlo Contreras
Code:
NCT04697576
Conditions
Clinical Stage I Cutaneous Melanoma AJCC V8
Clinical Stage IA Cutaneous Melanoma AJCC V8
Clinical Stage IB Cutaneous Melanoma AJCC V8
Clinical Stage II Cutaneous Melanoma AJCC V8
Clinical Stage IIA Cutaneous Melanoma AJCC V8
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Pembrolizumab
Quadrivalent Inactivated Influenza Vaccine
Resection
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations